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Abstract 
Two laboratories investigated the susceptibility of 106 Aeromonas salmonicida strains (from Denmark, France, Ireland, Norway 
and Scotland) to erythromycin, gentamicin, oxytetracycline and oxolinic acid using the disc diffusion protocols (M42-A) published 
by the Clinical and Laboratory Standards Institute. In studies of susceptibility to florfenicol an additional 15 Canadian strains were 
included. Comparison of the data generated by the two laboratories demonstrated that for each disc both detected a similar pattern 
of distribution but that there was a significant numerical difference in the zone sizes they recorded. Analysis of the extent of this 
lateral shift between the data generated in two laboratories indicated that the application of a single laboratory-independent 
epidemiological cut-off value for each disc could result in disagreement between the laboratories as to whether a strain should be 
classified as wild-type or non wild-type. 
Normalised resistance interpretation was employed to generate epidemiological cut-off values from the data obtained by each 
laboratory. The use of these laboratory-specific cut-off values resulted in both laboratories achieving complete agreement as to the 
classification of all strains to all agents. 
1. Introduction
A recent survey (Smith, 2006) indicated that the 
majority of laboratories, involved in investigating the 
susceptibility of clinical isolates from fish diseases, use 
disc diffusion methods. This survey also presented 
evidence of an increasing harmonisation of the disc 
diffusion protocols being employed, with the majority 
of the responding laboratories using either the earlier 
versions of CLSI M42-A (CLSI, 2006a) or the 
functionally equivalent protocols published by Alder- 
man and Smith (2001).  However, the survey also 
revealed that, despite the frequent use of similar test 
protocols, there was a considerable variation between 
laboratories with respect to the breakpoints they applied 
to the data they obtained. The current challenge is, 
therefore, to develop and validate a set of breakpoints 
that will allow the attribution of clinically relevant 
meaning to the inhibition zone data these laboratories 
generate. 
Clinically relevant breakpoints should provide crite- 
ria by which the data generated by testing any isolate 
could be used to determine whether, under the 
conditions of a proposed therapy, that strain should be 
considered as sensitive or resistant. Thus, in addition to 
data on the susceptibility of the organism, the setting of 
such breakpoints would require data on the pharmaco- 
kinetic and pharmacodynamic (PK/PD) aspects of the 
proposed therapy and on the clinical efficacy of previous 
therapies (MacGowan and Wise, 2001; CLSI, 2002; 
Kahlmeter et al., 2003). Even when all these data are 
available, Kahlmeter et al. (2003) have argued that the 
setting of clinical breakpoints is not and probably never 
will be, exact or strictly scientific. 
With respect to orally administered treatments of 
populations of poikilothermic animals, the acquisition 
of all the PK/PD data that would be required would 
present a number of theoretical (Coyne et al. 2004a,b, 
2006) and practical (Samuelsen, 2006) problems and 
would require a significant period of time (Smith, 2001). 
In contrast, data on the distributions of susceptibility for 
any particular group of bacteria associated with fish 
disease are relatively simple to accumulate. The 
European Committee on Antimicrobial Susceptibility 
Testing (EUCAST) (EUCAST, 2000) and CLSI (2002) 
have recommend that such distribution data can be used 
to estimate epidemiological cut-off values. These cut-off 
values can then be applied to the characterisation of 
isolates as wild type (WT) or non-wild type (NWT) on 
the basis of their relative susceptibility to a specific 
agent (EUCAST, 2000). 
Miller and Reimschuessel (2006) have used the 
Clinical and Laboratory Standards Institute (CLSI) 
standard protocols (CLSI, 2006a,b) to measure the 
susceptibility of 217 strains of Aeromonas. salmonicida 
to oxytetracycline, florfenicol, oxolinic acid and orme- 
toprim-sulfadimethoxine. They used these zone size and 
minimum inhibitory concentration (MIC) data to 
estimate epidemiological cut-off values (Kahlmeter 
et al., 2003; CLSI, 2002) for this species. Kahlmeter 
et al. (2003) have argued that, in the absence of clinical 
breakpoints, epidemiological cut-off values of the type 
established by Miller and Reimschuessel (2006) can be 
used to detect and monitor resistance. 
A central problem for any attempt to set universally 
applicable breakpoints or epidemiological cut-off values 
for disc diffusion data derives from the extent of the 
inter-laboratory variation that is associated with the data 
generated by this method (Kronvall, 1982, 2003; 
Kronvall et al., 1988). The development and application 
of strictly specified standard test protocols such as those 
recently published for bacteria isolated from aquatic 
animals (Alderman and Smith, 2001; CLSI, 2006a) aims 
to reduce the extent of this variation. However, 
increasing standardisation has been demonstrated only 
to minimise but not eliminate inter-laboratory variance 
(Kronvall, 2003). Inter-laboratory studies have been 
published of the data generated by three disc diffusion 
test protocols designed to examine bacteria associated 
with aquatic animals (Miller et al., 2003; NicGabhainn 
et al., 2003; Huys et al., 2005). All have reported 
significant inter-laboratory variance between the data 
generated by laboratories using the same test protocols. 
The width of the acceptable ranges for control strains in 
M42-A (CLSI, 2006a), which were generated from the 
standard deviations of data generated in nine laborato- 
ries (Miller et al. 2003), illustrate the extent to which 
inter-laboratory variation remains a problem even after 
rigorous standardisation. For A. salmonicida ACTC 
33658 incubated at 22 °C for 44–48 h the width of these 
acceptable ranges vary  from  11–16  mm  (median 
13 mm). 
Some workers have responded to the extent of inter- 
laboratory variation in disc diffusion data by abandon- 
ing any attempt to develop laboratory-independent, 
‘universal’ breakpoints for data generated by standard 
disc diffusion protocols. As an alternative, these work- 
ers (Kronvall et al. 1988; Manninen et al. 1995, 1998; 
Kronvall et al., 2003) have developed a variety of 
methods of producing valid but laboratory-specific, 
breakpoints. Single strain regression analysis (Forsberg 
et al. 1985; Kronvall and Ringertz, 1991), standard 
curve regression (Kronvall et al., 1988) and two-strain 
linear regression (Manninen et al., 1998) have all been 
suggested as methods of generating laboratory- and 
species-specific disc diffusion breakpoints. All these 
approaches, however, rely on the prior existence of a 
consensus MIC breakpoint. 
More recently Kronvall and his co-workers (Jone- 
berg et al., 2003; Kronvall, 2003; Kronvall et al, 2003) 
have developed a method of generating interpretative 
criteria for disc diffusion data that are both species- and 
laboratory-specific but that do not rely on the prior 
existence of a consensus MIC breakpoint. In essence 
this method, normalized resistance interpretation (NRI), 
approaches the setting of breakpoints from a consider- 
ation of the mean and standard deviation of the 
distribution of zone sizes obtained, for a set of 
susceptible (WT) strains of a particular species, in any 
particular laboratory. A core feature of NRI is that it 
calculates the parameters of the normal distribution of 
susceptible strain zone sizes from the high-zone end of 
the experimentally determined distributions. This allows 
NRI to characterise the susceptible strain data distribu- 
tion in a way that is not influenced or distorted by zones 
generated from strains with low-levels of resistance. 
The work reported here was undertaken to determine 
the influence of inter-laboratory variations in the 
determination of epidemiological cut-off values for 
disc diffusion data generated using the M42-A (CLSI, 
2006a) protocols. Given the fact that, with respect to 
bacteria associated with diseases of aquatic animals, no 
breakpoint MIC values have yet been established and 
the relatively urgent need for more rational interpreta- 
tive criteria for disc diffusion data (Smith, 2006), this 
work was also designed to investigate the value of the 
NRI approach to the setting of laboratory specific 
epidemiological cut-off values. 
2. Materials and methods
2.1. Laboratories 
The work reported here was performed in the Fish 
Health Unit laboratory of the Marine Institute, Oran- 
more, Galway Ireland (Laboratory 1) and that of the Fish 
Disease Group, Department of Microbiology, National 
University of Ireland Galway, Ireland (Laboratory 2). 
2.2. Bacteria 
In the studies with erythromycin (ERY), gentamicin 
(GEN), oxolinic acid (OXA) and oxytetracycline (OTC) 
106 strains of A. salmonicida were investigated. These 
strains were received from Scotland (33 strains), Norway 
(30 strains), Denmark (17 strains), France (15 strains) and 
Ireland (11 strains). In the studies with florfenicol (FLO) 
and additional 15 strains obtained from Canada were also 
included. All strains were brown pigmented and reacted 
with antiserum (BioNor MONO AQUA). 
Both laboratories obtained and maintained indepen- 
dent cultures of the control strain A. salmonicida 
NCIMB 1102 (equivalent to ACTC 33658) from the 
NCIMB (Aberdeen, UK). 
2.3. Media 
In both laboratories, bacteria were routinely cultured 
using Mueller Hinton Agar or Mueller Hinton Broth 
purchased from Mast Group (Bootle, UK). Incubations 
were performed at 22 ± 2 °C for 44–48 h. 
2.4. Discs 
Antimicrobial agent discs containing 15 μg erythro- 
mycin (ERY15), 10 μg gentamicin (GEN10), 30 μg 
florfenicol (FLO30), and 30 μg oxytetracycline (OTC30) 
were obtained from Oxoid (Basingstoke, UK). Labora- 
tory 1 obtained their 2 μg oxolinic acid (OXA2) from 
Mast Group (Bootle, UK) and Laboratory 2 obtained the 
same discs from Oxoid (Basingstoke, UK). 
2.5. Diffusion assay 
All disc diffusion assays were performed according 
to the protocols specified in M42-A (CLSI, 2006a). 
Suspensions were made in saline and incubations were 
at 22 ± 2 °C and zones were read after 44–48 h. 
A. salmonicida NCIMB 1102 was used as the control 
strain. 
2.6. Statistical analysis 
Normalised resistance interpretation was performed 
according to the method of Kronvall (2003) and 
Kronvall et al (2003). Peak values were established 
using 5 point rolling means and the mean and standard 
deviation of the real distribution of fully susceptible 
(wild type) strains were calculated using a plot of probit 
values against zone size. In each case 6 probit values 
were plotted and these included the first value N 5 and 
the next five values lower than this. Epidemiological 
cut-off values were set at two and a half standard 
deviations below the mean. 
All other statistical analyses were performed using 
InStat 3.0 (GraphPad Inc). 
3. Results
3.1. Compliance with acceptable ranges for control 
strain 
During this work, both laboratories performed 9 
independent measurements of the zones generated by 
each  of  the  five  discs  against  the  control  strain 
A. salmonicida NCIMB 1102. With respect to ERY10, 
GEN10, FLO30 and OXA2 all 72 individual measure- 
ments lay within the acceptable ranges specified in 
M42-A (CLSI, 2006a). For OTC30 all control strain 
zones determined by Laboratory 1 also lay within the 
acceptable range but the majority of the zones recorded 
by Laboratory 2 were larger than the upper limit of the 
acceptable range. Table 1 presents the mean zone sizes 
recorded by both laboratories. For Laboratory 1 the 
Table 1 
Comparison of the values (mm) reported by each laboratory for the 
control strain mean (n = 9) and for the mean and epidemiological cut- 
off values generated for fully susceptible (WT) strains by NRI analysis 
values against zone size was linear (r2 = 0.992) and the 
mean and standard deviations were 22.7 ± 3.3 mm. Thus, 
for these data the NRI analysis indicated a cut-off value 






NRI values for fully 
susceptible 
(WT) strains 
off values resulted in both laboratories categorising all 
106 strains as WT. 
3.2.2. Florfenicol 
Fig. 2a presents a scatter plot of the 121 paired zone 
sizes generated by the two laboratories using FLO30
discs. No major discrepancies were observed between 
the data generated by the two laboratories for any single 
Lateral shift was calculated as the difference (mm) between the values 
calculated by the two laboratories. 
All values were rounded off to the nearest mm before calculating 
lateral shift. 
mean values recorded for all agents were close to the 
lowest acceptable value. With the exception of those 
generated for OTC30 the control zones reported by 
Laboratory 2 were closer to, but always smaller than, the 
mid-point of the acceptable range. 
3.2. Estimations of epidemiological cut-off values 
3.2.1. Erythromycin 
Fig. 1a presents a scatter plot of the zone sizes 
generated by the two laboratories using discs containing 
15 μg erythromycin. The zones recorded for all 106 
strains fell into a single cluster and no major 
discrepancies were observed between the data generated 
by the two laboratories for any single strain. Fig. 1b 
presents the same data as a histogram. For the data from 
Laboratory 1 the plot of the probit values against zone 
size was linear (r2 = 0.994) and the mean and standard 
deviations were 18.9 ± 3.6 Thus, for these data the NRI 
analysis indicated a cut-off value of 10 mm (Fig. 1a and 
b). For the data from Laboratory 2, the plot of the probit 
Fig. 1. a. Scatter-plot of the zones recorded by Laboratories 1 and 2 
for discs containing 15 μg erythromycin against 106 strains of 
A. salmonicida. Vertical line indicates the epidemiological cut-off 
value calculated by Laboratory 1 and the horizontal line that for 
Laboratory 2. b. Zones obtained by Laboratories 1 and 2 for discs 
containing 15 μg erythromycin against 106 strains of A. salmonicida. 
Solid bars indicate data from Laboratory 1 and open bars those for 
Laboratory 2. The epidemiological cut-off values calculated by the two 
laboratories are shown as vertical lines. 
Mean  Mean Epidemiological 
cut-of value 
ERY 15 μg 19–31 1 21 19 10 
2 25 23 14 
Lateral 
shift⁎ 
4 4 4 
FLO 30 μg 34–47 1 36 36 27 
2 41 41 31 
Lateral 5 5 4 
shift 
GEN 10 μg 22–32 1 22 22 14 
2 26 26 19 
Lateral 4 4 5 
shift 
OTC 30 μg 28–38 1 32 34 25 
2 40 41 33 
Lateral 8 7 8 
shift 
OXA 2 μg 33–45 1 35 38 30 
2 39 41 33 
Lateral 4 3 3 
shift 
Fig. 2. a. Scatter-plot of the zones recorded by Laboratories 1 and 2 for 
discs containing 30 μg florfenicol against 121 strains of A. salmonicida. 
Vertical line indicates the epidemiological cut-off value calculated by 
Laboratory 1 and the horizontal line that for Laboratory 2. b. Zones 
obtained by Laboratories 1 and 2 for discs containing 30 μg florfenicol 
against 121 strains of A. salmonicida. Solid bars indicate data from 
Laboratory 1 and open bars those for Laboratory 2. The epidemiological 
cut-off values calculated by the two laboratories are shown as vertical 
lines. 
strain. Fig. 2b presents the same data as a histogram. For 
the data from Laboratory 1 the plot of the probit values 
against zone size was linear (r2 = 0.984) and the mean 
and standard deviations were 36.4 ± 3.7. Thus, for these 
data the NRI analysis indicated a cut-off value of 27 mm 
(Fig. 2a and b). For the data from Laboratory 2, the plot 
of the probit values against zone size was linear 
(r2 = 0.989) and the mean and standard deviations were 
40.9 ± 3.8 mm. Thus, for these data the NRI analysis 
indicated a cut-off value of 31 mm (Fig. 2a and b). The 
application of these cut-off values resulted in both 
laboratories categorising 6 strains, all originating from 
Canada, as NWT and the remaining 115 strains as WT. 
3.2.3. Gentamicin 
Fig. 3a presents a scatter plot of the zone sizes 
generated by the two laboratories using GEN10 discs 
containing. The zones recorded for all but one of the 106 
strains fell into a single cluster and no major 
discrepancies were observed between the data generated 
by the two laboratories for any single strain. Fig. 3b 
presents the same data as a histogram. For the data from 
Laboratory 1 the plot of the probit values against zone 
size was linear (r2 = 0.941) and the mean and standard 
deviations were 22.3 ± 3.4 mm. Thus, for these data the 
NRI analysis indicated a cut-off value of 14 mm (Fig. 3a 
Fig. 3. a. Scatter-plot of the zones recorded by Laboratories 1 and 2 
for discs containing 10 μg gentamicin against 106 strains of 
A. salmonicida. Vertical line indicates the epidemiological cut-off 
value calculated by Laboratory 1 and the horizontal line that for 
Laboratory 2. b. Zones obtained by Laboratories 1 and 2 for discs 
containing 10 μg gentamicin against 106 strains of A. salmonicida. 
Solid bars indicate data from Laboratory 1 and open bars those for 
Laboratory 2. The epidemiological cut-off values calculated by the two 
laboratories are shown as vertical lines. 
Fig. 4. a. Scatter-plot of the zones recorded by Laboratories 1 and 2 for 
discs containing 2 μg oxolinic acid against 106 strains of A. salmonicida. 
Vertical line indicates the epidemiological cut-off value calculated by 
Laboratory 1 and the horizontal line that for Laboratory 2. b. Zones 
obtained by Laboratories 1 and 2 for discs containing 30 μg oxy- 
tetracycline against 106 strains of A. salmonicida. Solid bars indicate data 
from Laboratory 1 and open bars those for Laboratory 2. The epide- 
miological cut-off values calculated by the two laboratories are shown as 
vertical lines. 
and b). For the data from Laboratory 2, the plot of the 
probit values against zone size was linear (r2 = 0.985) 
and the mean and standard deviations were 25.5 ± 
2.5 mm. Thus, for these data, the NRI analysis indicated 
a cut-off value of 19 mm (Fig. 3a and b). Using the cut- 
off values calculated from their data, both laboratories 
classified one strain, originating in Scotland, as NWT 
and the other 105 as WT. 
3.2.4. Oxolinic acid 
Fig. 4a presents a scatter plot of the zone sizes 
generated by the two laboratories using OXA2 discs. No 
major discrepancies were observed between the data 
generated by the two laboratories for any single strain. 
Fig. 4b presents the same data as a histogram. For the 
data from Laboratory 1 the plot of the probit values 
against zone size was linear (r2 = 0.961) and the mean 
and standard deviations were 38.4 ± 3.2 mm. Thus, for 
these data, the NRI analysis indicated a cut-off value of 
30 mm (Fig. 4a and b). For the data from Laboratory 2, 
the plot of the probit values against zone size was linear 
(r2 = 0.984) and the mean and standard deviations were 
40.5 ± 2.9 mm. Thus, for these data, the NRI analysis 
Fig. 5. a. Scatter-plot of the zones recorded by Laboratories 1 and 2 
for discs containing 30 µg oxytetracycline against 106 strains of 
A. salmonicida. Vertical line indicates the epidemiological cut-off 
value calculated by Laboratory 1 and the horizontal line that for 
Laboratory 2. b. Zones obtained by Laboratories 1 and 2 for discs 
containing 30 μg oxytetracycline against 106 strains of A. salmonicida. 
Solid bars indicate data from Laboratory 1 and open bars those for 
Laboratory 2. The epidemiological cut-off values calculated by the two 
laboratories are shown as vertical lines. 
indicated a cut-off value of 33 mm (Fig. 4a and b). Using 
the cut-off values calculated from their data both 
laboratories classified 60 strains as NWT and 46 strains 
as WT. 
3.2.5. Oxytetracycline 
Fig. 5a presents a scatter plot of the zone sizes 
generated by the two laboratories using OXA2 discs. No 
major discrepancies were observed between the data 
generated by the two laboratories for any single strain. 
Fig. 5b presents the same data as a histogram. For the 
data from Laboratory 1 the plot of the probit values 
against zone size was linear (r2 = 0.995) and the mean 
and standard deviations were 34.4 ± 3.8 mm. Thus, for 
these data the NRI analysis indicated a cut-off value of 
25 mm (Fig. 5a and b). For the data from Laboratory 2, 
the plot of the probit values against zone size was linear 
(r2 = 0.987) and the mean and standard deviations were 
41.2 ± 3.4 mm. Thus, for these data the NRI analysis 
indicated a cut-off value of 33 mm (Fig. 5a and b). Using 
the cut-off values calculated from their data both 
laboratories classified 51 strains as NWT and 55 strains 
as WT. Fifty of the NWT strains gave zones in a tight 
cluster but one strain gave zones intermediate between 
this cluster and those generated by the other WT strains. 
4. Discussion
4.1. Strategies for setting epidemiological cut-off values 
One strategy for setting disc diffusion cut-off values 
for bacteria associated with fish disease is to attempt to 
deal with the problem of inter-laboratory variation by 
developing a rigorously specified standard protocol. This 
strategy underlay the development of the Alderman and 
Smith (2001) protocols and the M42-A protocols of the 
CLSI (2006a). For Group 1 bacteria such as A. 
salmonicida, these protocols are functionally equivalent 
but the inclusion, by M42-A, of acceptable ranges for 
control strains represents a valuable development. The 
assumption was that epidemiological cut-off values could 
be generated (Miller and Reimschuessel, 2006) that could 
be treated as ‘universal’ in that they could be validly 
applied by any laboratory that was in compliance with the 
acceptable ranges specified in M42-A (CLSI, 2006a). 
An alternative strategy to setting breakpoints starts 
from the assumption that inter-laboratory variation is 
significant and cannot adequately be dealt with by 
increasing the rigour with which disc diffusion protocols 
are specified (Kronvall, 1982). Thus, this approach does 
not aim at the generation of ‘universal’ epidemiological 
cut-off values but adopts a strategy aimed at developing 
a universal method for setting laboratory-specific 
epidemiological cut-off values. 
One of the key factors in making a decision between 
these two strategies will be the extent to which inter- 
laboratory variation in the performance of disc diffusion 
tests (NicGabhainn et al., 2003) result in significant 
differences, lateral shift, between the numerical data 
obtained by different laboratories examining the same 
strain set. 
4.2. Evidence for lateral shift in distributions 
In this work, two laboratories, using the same 
standard disc diffusion protocol to examine the same 
strain set, produced data that showed very similar 
distribution patterns (Figs. 1a, 2a, 3a, 4a and 5a). Figs. 
1b, 2b, 3b, 4b and 5b, however, demonstrate that, for 
all five discs, there was a significant (t-test; p b 0.05) 
difference (data not shown) in the numerical values of 
the zone sizes recorded by the two laboratories. Table 1 
presents the impact of these differences on the means 
recorded for the control strain and for the means and 
cut-off values estimated for WT strains by NRI analysis 
by the two laboratories. This suggests that, for any 
specific disc, lateral shift, the numerical difference in 
the data produced by two laboratories, is a parameter 
that can be approximately characterised by a single 
number. 
The acceptable zone sizes specified in M42-A (CLSI, 
2006a) for the A. salmonicida control strain incubated at 
22 ± 2 °C and read at 44–48 h are quite wide. For the 
discs used in this work they cover 11–14 mm (Table 1). 
The similarity, observed in this work, between the lateral 
shift in the epidemiological cut-off values and the lateral 
shift in the control strain means would suggest, 
therefore, that epidemiological cut-off values estab- 
lished by different laboratories, all in compliance with 
M42-A, could also vary over a similar, if slightly 
smaller, range. Even if the ‘universal’ cut-off value was 
established in a laboratory where the control strain mean 
was in the centre of the acceptable range, this cut-off 
value could be up to 5–6 mm distant from one that 
would be optimal for the data generated by another 
laboratory in full compliance with M42-A (CLSI, 
2006a). 
4.3. The significance of lateral shift for the universal 
application of laboratory-independent cut-off values 
In order to discuss the significance of laboratory- 
specific lateral shift for the application of universal 
epidemiological cut-off values it is useful to consider 
two types of error that might arise. Type 1 errors can 
arise when the universal cut-off values were generated 
in a laboratory where zone sizes are normally smaller 
than those in the laboratory applying them. Thus, type 1 
errors would result in the laboratory applying the 
universal cut-off values classifying NWT strains as 
WT. The second (type 2) errors can occur when the 
universal cut-off values were generated in a laboratory 
where zone sizes are normally larger that in the 
laboratory applying them. Type 2 errors result in the 
classification of some WT strains as NWT. 
In this work the lateral shift resulted in the 
epidemiological cut-off values estimated from Labora- 
tory 1 data being, in all cases, smaller than those 
estimated from Laboratory 2 data (Tables 1 and 2). In 
two of the three case where a comparison can be made 
the Laboratory 1 cut-off values were also lower than 
those suggested by Miller and Reimschuessel (2006) 
(Table 2). 
4.3.1. Type 1 errors 
Type 1 errors result in the failure to correctly identify 
strains with a NWT phenotype. In situations were a 
NWT phenotype results from the acquisition of a gene 
encoding a specific, positive function resistance (Sørum, 
2006) then it is reasonable to assume that the decrease in 
susceptibility would normally result in a large reduction 
in zone size (Uhland and Higgins, 2006). As a con- 
sequence, it is difficult to envisage a situation where the 
degree of lateral shift in the zone diameter data gen- 
erated by a laboratory, would result in the failure to 
identify such strains. 
Table 2 
The frequency of strains originally classified as wild type (WT) by 
Laboratory 1 that would not have been placed in this group if 
 epidemiological cut-off values from other sources had been applied    
Disc Epidemiological cut-off values Frequency 
However, there are data indicating that mechanisms 
other than the acquisition of specific genes can result in 
reduced susceptibility. Mechanisms such as multiple 
low-level resistance (Barnes et al., 1990, 1992; Griffiths 
and Lynch, 1989; Woods et al., 1986), efflux systems 
(Giraud et al., 2004; Poole, 2005), outer membrane 
changes (Nikaido, 1989) and even phenotypic, persis- 
tence mechanisms (Balaban et al., 2004; Levin, 2004) 
may result in much smaller changes in zone size. It is in 
the classification of strains manifesting low-level 
resistance that type 1 errors are most likely to occur. 
The application of the cut-off values from Laboratory 
1 or those of Miller and Reimschuessel (2006) to the 
data obtained in this work by Laboratory 2 would not 
have resulted in any type 1 errors. This absence of type 1 
errors must be understood in the context of the rarity in 
the strain set studied of any strains that gave zones 
consistent with the possession of a low-level resistance 
mechanism. It should, however, be noted that other 
authors, for example Thyssen and Ollevier (2001) and 
Smith and Christofilogiannis (in press), have produced 
data that indicates a higher frequency of these mechan- 
isms in the strain sets they studied. Smith et al. (1994) 
have suggested that some low-level resistance pheno- 
types, particularly with respect to quinolone agents, are 
unstable during storage. Thus, it is possible that the low 
frequency of strains manifesting low-level resistance 
might be related to the fact that the majority of strains 
studied in this work had been stored for a number of 
years. 
4.3.2. Type 2 errors 
Type 2 errors, caused by the application in a specific 
laboratory of an epidemiological cut-off value that is too 
large, result in the failure to correctly identify a strain as 
WT. In this work the cut-off values calculated by 
Laboratory 2 were, in all cases, larger than those 
calculated by Laboratory 1. In addition two of the three 
cut-off values set by Miller and Reimschuessel (2006) 
Lab 1 Alternative sources (%) of type were larger than those of Laboratory 1. Table 2 presents 
   2 errors 
⁎ The source indicated as M and R was Miller and Reimschuessel 
(2006). 
⁎⁎ Laboratory 2 was out of compliance with the acceptable ranges 
specified in M42-A for OTC30 discs. 
the consequences that would have arisen if the data 
generated by Laboratory 1 had been interpreted using 
the cut-off values from Laboratory 2 or those suggested 
by Miller and Reimschuessel (2006). Laboratory 2 was, 
however, out of compliance with respect to OTC30, it 
would not have been legitimate, therefore, to attempt to 
generate an M42-A (CLSI, 2006a) applicable, labora- 
tory-independent cut-off value from their data for this 
disc. Thus, the demonstration that the application by 
Laboratory 1 of the OTC cut-off values calculated by 
Laboratory 2 would have resulted in a miss-classifica- 
tion of 23% of the strains has only limited relevance. 
Value (mm) Source Value (mm) 
ERY 15 μg ≥ 10 Lab 2 ≥ 14 0 
FLO 30 μg ≥ 27 Lab 2 ≥ 31 7/114 (6%) 
M and R ⁎ ≥ 31 7/114 (6%) 
GEN 10 μg ≥ 14 Lab 2 ≥ 19 3/105 (3%) 
OTC 30 μg ≥ 25 Lab 2 ≥ 32 ⁎⁎ 13/56 (23%) 
M and R ≥ 28 0 
OXA 2 μg ≥ 30 Lab 2 ≥ 33 4/46 (9%) 
M and R ≥ 30 0 
However, with respect to the other discs, the application 
of Laboratory 2 cut-off values to Laboratory 1 data 
would have resulted in type 2 errors occurring with a 
frequency of zero for ERY15, 6% for FLO30, 3% for 
GEN10 and 9% for OXA2. Application, by Laboratory 1, 
of the epidemiological cut-off value suggested by Miller 
and Reimschuessel (2006) for FLO30 would have 
resulted in type 2 errors with a frequency of 6%. 
These arguments demonstrate that the problems that 
lateral shift presents for the development of laboratory- 
independent are not just theoretical and hypothetical. 
4.4. Application of NRI analysis 
Figs. 1a, 2a, 3a, 4a and 5a demonstrate that the 
application of laboratory specific cut-off values gener- 
ated by NRI analysis resulted in a complete agreement 
between the two laboratories as to the classification (WT 
or NWT) of all strains. This agreement was achieved 
despite the existence of significant lateral shift (Table 1) 
between the data generated by the two laboratories. This 
agreement was also achieved despite the failure of 
Laboratory 2 to obtain zones for OTC30 that were within 
the acceptable range for M42-A (CLSI, 2006a). 
Compliance with the acceptable ranges for OTC30
has been a continuing problem for Laboratory 2 where 
supplementation of the Mueller-Hinton agar with 
divalent ions has been found to be necessary to achieve 
compliance with the specifications of M42-A (CLSI, 
2006a). The approach of rigorous standardisation to the 
setting of cut-off values would require that, as the 
OTC30 data obtained by Laboratory 2 for the control 
strain was out of compliance with M42-A (CLSI, 
2006a), the OTC30 data for the other 106 strains should 
not be considered as having been generated by a 
legitimate application of M42-A (CLSI, 2006a). As a 
consequence, any epidemiological cut-off values estab- 
lished for this protocol should not be applied to the 
interpretation of OTC30 data from Laboratory 2. 
Equally, the OTC30 data from Laboratory 2 could not 
be used to generate cut-off values for data generated by 
this protocol. If the approach of rigorous standardisation 
and laboratory-independent cut-off values were 
adopted, Laboratory 2 would have to modify its test 
protocol, until it could achieve compliance with the 
acceptable ranges specified in M42-A (CLSI, 2006a), 
before it could interpret any of the data it generated from 
clinical isolates. It is a clear advantage of the application 
of NRI analysis to setting laboratory-specific cut-off 
values, that it would allow Laboratory 2 to interpret their 
OTC30 data without modifying their performance of the 
test protocol. 
4.4.1. Ambiguity in classification of strains 
With respect to GEN10 and OTC30 the cut-off values 
set by each laboratory provided an unambiguous 
separation of strains on the basis of their zone sizes. 
With respect to OXA2 Laboratory 1 recorded one strain 
at its cut-off value. For the same strain Laboratory 2 
recorded a zone size in the middle of the WT cluster 
suggesting that its classification as WT was probably 
correct. With respect to FLO30 there was, however, one 
strain that both laboratories placed close to their 
respective cut-off values (Fig. 2a). Miller and Reim- 
schuessel (2006) set their disc diffusion epidemiological 
cut-off value for florfenicol such that 2% of their strains 
gave zones slightly below that value. The MIC values 
recorded for these strains did not, however, confirm 
their NWT status. Michel et al. (2005) reported that the 
presence of efflux pump inhibitors resulted in a 4 mm 
increase in zone size of A. salmonicida against FLO30
and this suggests that such pumps may mediate slight 
reduction in susceptibility to florfenicol in this strain. 
These observations suggest that continuing attention 
should be paid to strains that generate zones close to any 
cut-off value set for FLO30 discs. 
4.4.2. Patterns of susceptibility analysed by agent 
Although, with the exception of Norway (Lunestad 
and Grave, 2005) it is difficult to obtain quantitative data 
on the use of different antimicrobials in aquaculture, the 
frequency of NWT phenotypes to the different agents 
tested generally reflected the frequency with which they 
are believed to be employed in the control of furunculosis 
(Hastings, 1997). The very low frequencies of strains 
classified as NWT with respect to erythromycin and 
gentamicin are consistent with our understanding that 
Table 3 
Distance between epidemiological cut-off values for WT strains and 
the means for control strain (n = 9) and the WT group mean calculated 
by NRI analysis 
Disc Lab Distance (mm) of epidemiological 
cut-off value from 
Control strain mean WT mean 
ERY 15 μg 1 11 9 
2 11 9 
FLO 30 μg 1 9 9 
2 10 10 
GEN 10 μg 1 8 8 
2 7 7 
OTC 30 μg 1 7 9 
2 8 9 
OXA 2 μg 1 5 8 
2 6 8 
these agents are rarely, if ever, used to treat furunculosis in 
European aquaculture. In contrast, the relatively high 
frequencies of OTCNWT (48%) and OXANWT (57%) 
phenotypes are consistent with the widespread use of 
these agents. With respect to florfenicol none of the 
European strains were classified as NWT. This may 
reflect the fact that many of the strains had been originally 
isolated before the widespread use of this agent in 
European aquaculture. However Michel et al. (2003) have 
reported that widespread use of florfenicol in France had 
not resulted in high frequencies of resistance in strains 
isolated in that country. 
4.4.3. Patterns of susceptibility analysed by country 
The strain set used in this work was composed of 
strains from 5 or, in the case of florfenicol, 6 countries. 
However, the various national collections were not 
isolated during the same time-period and were not 
composed of similar numbers of strains. Furthermore 
none of the national strain sets had been selected as being 
representative of the A. salmonicida in that area. For these 
reasons no attempt has been made to provide an analysis 
of the distribution of NWT phenotypes by country. 
4.4.4. Similarity in the spread of zones for susceptible 
(WT) strains 
The NRI method allows the calculation of the mean 
and standard deviations of the real distribution of the 
zone sizes of fully susceptible (WT) strains. In this work 
there was a considerable agreements in these NRI 
estimated standard deviations for all five agents 
recorded by both laboratories. The 10 standard devia- 
tions calculated ranged from 2.5 mm to 3.8 mm with a 
mean of 3.4 ± 0.4 mm. As the NRI method calculates the 
epidemiological cut-off value from the mean and the 
standard deviation, the similarity of the standard 
deviations has the consequence that there is a remark- 
ably similar distance between the NRI means and the 
epidemiological cut-off values for all agents in both 
laboratories (mean± sd, 8.6 ± 0.8 mm) (Table 3). The 
distance between the epidemiological cut-off values and 
the control strain means (11 mm–5 mm; median 8 mm) 
shows a greater degree of variation. 
5. Conclusions
This work has demonstrated that significant lateral 
shift can be expected between the disc diffusion data 
generated in different laboratories even when these 
laboratories generated control strain data that is in 
compliance with the specification of a standard protocol. 
It has also been demonstrated that the extent of the lateral 
shift is sufficient to lead to problems for the application of 
laboratory-independent epidemiological cut-off values. 
The NRI method was demonstrated to provide a method 
of generating laboratory-specific epidemiological cut-off 
values. The two laboratories in this study obtained 
complete agreement in the categorisation of all strains 
with respect to 5 agents when they used cut-off values 
developed by the application of NRI analysis to their own 
data. 
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